Docetaxel for Breast Cancer
This trial looks at two different drugs to see how well they reduce chemotherapy-induced nerve damage in African American patients with early to mid-stage breast cancer.
- Breast Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How widely is this investigation being conducted?
"This trial is currently recruiting from a total of 100 different centres, including Aria Health-Torresdale Campus in Philadelphia, Aurora Cancer Care-Southern Lakes VLCC in Burlington, and 21st Century Oncology-Henderson in Henderson."
Have other research projects employed Docetaxel as a component?
"Currently, 1088 trials investigating the efficacy of Docetaxel are in progress. Of those active studies, 317 have reached Phase 3 status. Although Shanghai is by far the most popular area for these trails to be conducted (58781 locations), other areas worldwide have launched investigations as well."
To what degree does Docetaxel pose a risk to patients?
"Considering the Phase 2 status of Docetaxel, there is sufficient clinical data to validate its safety but none to demonstrate efficacy; thus it was assigned a score of 2."
What maladies is Docetaxel employed to remedy?
"Docetaxel is the go-to option for neoplasm metastasis, and can also be beneficial in treating a variety of other medical conditions such as soft tissue sarcoma (STS), locally advanced non-small cell lung cancer, or even metastatic bladder cancer."
How many participants are being included in this clinical trial?
"This medical trial has closed its recruitment window. The study was initially listed on June 27th, 2019 and the last update occurred April 14th, 2022. Currently, there are 2432 studies recruiting participants with breast conditions and 1088 trials accepting volunteers for Docetaxel research."
Is the enrollment process for this study still open?
"The data found on clinicaltrials.gov displays that this medical trial is not open for enrollment any longer, as the last update was in April of 2022 and it first began recruiting patients back in June 2019. While recruitment has ceased, there are still 3520 other trials searching for volunteers across the globe."